While the FDA dominates GLP-1 compounding headlines, state pharmacy boards are the primary regulators of 503A compounding pharmacies — and many are conducting their own investigations and enforcement actions. Here's what's happening at the state level.

Why State Actions Matter
503A pharmacies are licensed by state boards of pharmacy, not the FDA. While the FDA sets federal standards, state boards conduct inspections, investigate complaints, and can suspend or revoke pharmacy licenses. A pharmacy can be in full FDA compliance and still face state board action — and vice versa.

States With Active Enforcement

Several states have taken notable actions regarding GLP-1 compounding in the first half of 2026. The pattern generally involves one of three triggers: patient complaints about adverse events, proactive inspections following FDA guidance changes, or referrals from manufacturer litigation.

California has been among the most active, with the Board of Pharmacy conducting targeted inspections of pharmacies advertising compounded semaglutide online. The focus has been on pharmacies compounding for patients in states where they don't hold licensure — a common compliance gap in the telehealth-driven model.

Texas remains a key battleground. The Northern District of Texas has been the venue for OFA's challenges to FDA shortage determinations, and the Texas State Board of Pharmacy has been navigating the tension between supporting compounding access (politically popular in Texas) and enforcing federal compliance requirements.

Florida has seen enforcement focused on pharmacies operating without proper sterile compounding certifications — a particular concern for injectable GLP-1 preparations.

Interstate Compounding: The Unresolved Issue

One of the most significant unresolved regulatory questions is interstate compounding. A pharmacy licensed in State A that fills prescriptions for patients in State B may need to be licensed in both states. Many states require out-of-state pharmacies to obtain a non-resident pharmacy license before dispensing to their residents. Not all compounding pharmacies have done this — and state boards are increasingly checking.

Before using any compounding pharmacy, verify: the pharmacy is licensed in its home state AND holds a non-resident license (or equivalent) in your state. Your state board of pharmacy website typically has a license verification tool.

What Patients Should Do

State-level enforcement is generally a positive development for patient safety. The actions target pharmacies with genuine compliance deficiencies — not patients. But if your provider faces state board action, you may need to transition to a new pharmacy. Maintain records of your prescription, dosing history, and provider relationship to facilitate a smooth transition if needed.

Verify Your Provider's Licensure

All providers in our directory maintain current licensure. Check your options.

See Verified Providers →